Crossmark

Investigating the clinical efficacy, safety and molecular mechanism of sulforaphane in autism spectrum disorder: an integrated study combining meta-analysis, network pharmacology, and computational biology

Crossref DOI link: https://doi.org/10.1186/s40360-025-01052-5

Published Online: 2025-11-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Long, Junzi

Liao, Xingxing

Tang, Zhiqing

Han, Kaiyue

Chen, Jiarou

Wang, Xianna

Liu, Jianjun

Zhang, Yan

Zhang, Hao
Funding

Funding for this research was provided by:

China Disabled Persons’ Federation (CDPF2023KF00001)
License Information

Text and Data Mining valid from 2025-11-22

Version of Record valid from 2025-12-30
More Information

Article History

Received: 17 October 2025

Accepted: 20 November 2025

First Online: 22 November 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below